...
首页> 外文期刊>JACC. Cardiovascular interventions >Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention The ETAMI Trial (Early Thienopyridine treatment to improve primary PCI in Patients with Acute Myocardial Infarction)
【24h】

Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention The ETAMI Trial (Early Thienopyridine treatment to improve primary PCI in Patients with Acute Myocardial Infarction)

机译:急性ST段抬高型心肌梗死计划进行首次经皮介入治疗的患者的600 mg氯吡格雷与60 mg普拉格雷的双剂量,随机,前瞻性比较ETAMI试验(早期噻吩并吡啶治疗可改善急性心肌炎患者的主要PCI)梗塞)

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES This study compared the timing of onset of antiplatelet action after treatment with clopidogrel and prasugrel at first medical contact in patients with ST-segment elevation myocardial infarction (STEMI) scheduled for primary percutaneous coronary intervention (PPCI).
机译:目的本研究比较了计划行原发性经皮冠状动脉介入治疗(STPCI)的ST段抬高型心肌梗死(STEMI)患者在首次就医时使用氯吡格雷和普拉格雷治疗后抗血小板作用开始的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号